Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History $15.03 -0.67 (-4.27%) Closing price 04:00 PM EasternExtended Trading$14.92 -0.10 (-0.70%) As of 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cadrenal Therapeutics Stock Price Performance The Cadrenal Therapeutics (CVKD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 3.73%. In the past month, the stock has decreased 10.22%, reflecting recent market activity. As of the latest close, Cadrenal Therapeutics traded at $15.70 with a market cap of $30.88 million and volume of 9,300 shares. Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.03%1 Month Performance-10.22%3 Month Performance-24.43%Year-To-Date Performance+3.73% CVKD Stock Chart for Thursday, May, 22, 2025 CVKD Chart by TradingView Cadrenal Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$15.68$15.70+0.13%$15.85$15.089,300 shs$30.88 million05/20/2025$15.35$15.68+2.15%$15.74$14.9610,807 shs$30.84 million05/19/2025$15.50$15.35-0.97%$15.63$14.8013,307 shs$30.19 million05/16/2025$15.14$15.50+2.38%$16.25$15.1628,965 shs$30.49 million05/15/2025$14.14$15.14+7.07%$15.31$13.7630,757 shs$29.37 million05/14/2025$14.79$14.14-4.39%$14.67$13.5724,082 shs$27.43 million05/13/2025$13.38$14.79+10.54%$14.95$13.1044,773 shs$28.69 million05/12/2025$14.25$13.38-6.11%$15.83$13.2746,474 shs$25.96 million05/09/2025$15.66$14.25-8.97%$15.97$14.2038,425 shs$27.65 million05/08/2025$16.27$15.66-3.78%$16.50$15.3047,772 shs$30.37 million Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$15.68$16.27+3.76%$16.31$15.2913,411 shs$31.56 million05/06/2025$16.34$15.68-4.04%$16.34$15.618,447 shs$30.42 million05/05/2025$16.45$16.34-0.67%$16.75$16.0514,973 shs$31.70 million05/02/2025$16.50$16.45-0.30%$17.00$16.2927,836 shs$31.91 million05/01/2025$16.42$16.50+0.49%$16.90$16.1133,488 shs$32.01 million04/30/2025$16.78$16.42-2.15%$16.67$16.0514,529 shs$31.86 million04/29/2025$17.36$16.78-3.34%$17.40$16.5515,096 shs$32.55 million04/28/2025$16.80$17.36+3.33%$17.50$16.8018,930 shs$33.68 million04/25/2025$17.00$16.80-1.18%$17.23$16.6612,554 shs$31.58 million04/24/2025$16.88$17.00+0.71%$17.21$16.6521,056 shs$31.96 million04/23/2025$16.74$16.88+0.84%$17.00$16.1519,606 shs$31.73 million04/22/2025$16.18$16.74+3.46%$16.75$15.8515,574 shs$31.47 million04/21/2025$16.75$16.18-3.40%$17.04$16.0520,050 shs$30.42 million Related Companies COYA Stock Chart SGMT Stock Chart IVVD Stock Chart MGNX Stock Chart BDTX Stock Chart CTNM Stock Chart ENTX Stock Chart KYTX Stock Chart OPTN Stock Chart HLVX Stock Chart Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CVKD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
